Glucose homeostasis is the tight hormonal regulation of blood glucose levels within a narrow physiological range, typically between 3.9 and 5.6 mmol/L in the fasting state. The brain and red blood cells are obligate glucose consumers, making glucose regulation critical for survival.
The Fed State
After a meal, blood glucose rises and triggers insulin secretion from the pancreatic beta cells. Insulin promotes glucose uptake into muscle and adipose tissue by stimulating the translocation of GLUT4 transporters to the cell surface. In the liver, insulin suppresses gluconeogenesis and glycogenolysis while stimulating glycogen synthesis and glycolysis. Excess glucose is converted to fatty acids and stored as triglycerides in adipose tissue.
The Fasting State
As blood glucose falls between meals, the pancreatic alpha cells secrete glucagon. Glucagon acts primarily on the liver to stimulate glycogenolysis, releasing glucose into the bloodstream. Hepatic gluconeogenesis is activated to produce glucose from lactate, amino acids, and glycerol. Muscle and adipose tissue switch from glucose to fatty acid oxidation, sparing glucose for the brain.
Hormonal Regulation
Insulin is the primary anabolic hormone, lowering blood glucose by promoting uptake, storage, and utilization. It is secreted in response to elevated blood glucose, with additional signals from incretin hormones like GLP-1 and GIP. Insulin signaling through the insulin receptor activates a cascade of phosphorylation events that regulate metabolic enzyme activity and gene expression.
Glucagon is the primary counter-regulatory hormone, raising blood glucose during fasting. It binds to the glucagon receptor on hepatocytes, activating adenylyl cyclase and increasing cAMP levels. This activates protein kinase A, which phosphorylates and activates glycogen phosphorylase while inhibiting glycogen synthase.
Epinephrine provides rapid glucose mobilization during stress or exercise, acting on both liver and muscle to stimulate glycogenolysis. Cortisol promotes gluconeogenesis and reduces glucose uptake, exerting longer-term effects. Growth hormone antagonizes insulin action and is important for maintaining glucose levels during prolonged fasting.
The Glucose-Insulin Feedback Loop
Blood glucose concentration is maintained by a classic negative feedback loop. Rising glucose stimulates insulin secretion, which lowers glucose by promoting uptake and storage. Falling glucose inhibits insulin release and stimulates glucagon secretion, which raises glucose by promoting production. The beta cells of the pancreas sense glucose concentration directly through GLUT2 and glucokinase, which acts as the glucose sensor.
Hypoglycemia
Hypoglycemia, defined as blood glucose below 3.9 mmol/L, can result from excessive insulin or insulin-mimetic drugs, prolonged fasting, or insulin-secreting tumors. Symptoms include autonomic responses such as sweating, tremor, and palpitations, followed by neuroglycopenic symptoms including confusion, seizure, and coma if untreated. The body responds with counter-regulatory hormone release, but this response can be impaired in individuals with recurrent hypoglycemia.
Hyperglycemia and Diabetes
Chronic hyperglycemia is the hallmark of diabetes mellitus. Type 1 diabetes results from autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency. Type 2 diabetes involves insulin resistance combined with progressive beta cell dysfunction. Gestational diabetes occurs during pregnancy and resolves after delivery but increases future diabetes risk. Chronic hyperglycemia causes microvascular complications including retinopathy, nephropathy, and neuropathy, as well as accelerated macrovascular disease.
